debt offering

Scorpio Tankers raises $200M in convertible notes due 2031 at premium pricing, launches concurrent $55M stock buyback, signaling management confidence.

Canadian National Railway launches $750M debt offering with two tranches maturing in 2029 and 2036, proceeds earmarked for general corporate purposes and debt refinancing.

CN Railway raises $750M through dual-tranche debt offering, refinancing commercial paper with 2029 and 2036 senior notes at 4.350% and 4.950% respectively.

Marex Group prices $500 million senior notes at 5.680% due 2031, strong investor demand signals confidence in the firm's financial strategy and growth prospects.

Brookfield prices C$750M in medium-term notes due 2036 and 2055 at investment-grade ratings, demonstrating strong capital market access.

Brookfield Asset Management prices $550M of 2031 notes at 4.832% and reopens $450M of 2036 notes at 5.298%, raising $1B for general corporate purposes.

Scorpio Tankers prices $325M convertible notes due 2031 at 1.75%, up from $300M plan. Concurrent $100M share repurchase of 1.34M shares at $74.36.

Millicom reopens 7.375% Senior Notes due 2032, raising $75M via private placement to fund capital expenditures and potential acquisitions.

JD.com prices CNY10 billion bond offering with two tranches at 2.05% and 2.75% coupons, closing April 2026, emphasizing debt repayment and financial optimization.

Sasol's US subsidiary prices $750M senior notes due 2033 at 8.75% coupon. Proceeds will refinance existing debt and fund corporate operations.

Rogers Communications prices $2.5B dual-currency subordinated notes offering, with proceeds directed toward debt refinancing through 2056 maturity.

Harrow prices $50M in senior unsecured notes due 2030, expanding existing debt facility for product development and strategic initiatives.

Indivior prices $450M convertible notes offering, upsized from $400M, to refinance debt and fund share buybacks through 2031.

Indivior plans $400M convertible notes offering to refinance debt and fund buybacks, reflecting broader pharmaceutical sector refinancing trends.

California Resources priced $350M of 7% notes due 2034 to refinance higher-cost 8.25% debt maturing in 2029, reducing interest expenses.

Baker Hughes prices $9.5B debt offering to fund Chart Industries acquisition, with notes maturing through 2056 and closing expected March 11, 2026.

Dave Inc. prices $175M convertible notes at 0% with 32.5% conversion premium, plans $70.5M share buyback using proceeds.

Verisk Analytics raises $1 billion through dual-tranche senior notes offering to refinance existing borrowings and optimize its debt structure.

Regency Centers raises $450M in seven-year senior notes at 4.50% to refinance debt, reduce borrowings, and fund capital projects through 2033.